Bailard, Inc. Merck & Co., Inc. Transaction History

Bailard, Inc.

$3.58 Billion
Q1 2024

A detailed history of Bailard, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bailard, Inc. holds 42,902 shares of MRK stock, worth $5.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

42,902

Previous 45,576 5.87%

Holding current value

$5.4 Million

Previous $4.97 Million 13.93%

% of portfolio

0.16%

Previous 0.15%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $302,803 - $352,834	-2,674 Reduced 5.87%	42,902 $5.66 Million
Q4 2023 Feb 02, 2024	SELL	$100.18 - $109.02 $210,578 - $229,160	-2,102 Reduced 4.41%	45,576 $4.97 Million
Q3 2023 Oct 24, 2023	BUY	$102.95 - $114.33 $380,709 - $422,792	3,698 Added 8.41%	47,678 $4.91 Million
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $40,511 - $44,155	-373 Reduced 0.84%	43,980 $5.07 Million
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $12,352 - $13,783	120 Added 0.27%	44,353 $4.72 Million

Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $101,867 - $130,608	-1,165 Reduced 2.57%	44,233 $4.91 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $260,521 - $292,666	3,082 Added 7.28%	45,398 $3.91 Million
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $727,782 - $824,976	8,717 Added 25.94%	42,316 $3.86 Million
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $115,778 - $129,780	1,575 Added 4.92%	33,599 $2.76 Million
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $40,765 - $51,064	-564 Reduced 1.73%	32,024 $2.45 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $144,578 - $159,000	-2,017 Reduced 5.83%	32,588 $2.45 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $5.07 Million - $5.61 Million	-72,097 Reduced 67.57%	34,605 $2.69 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $17,697 - $20,845	-257 Reduced 0.24%	106,702 $8.23 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $220,118 - $244,286	3,067 Added 2.95%	106,959 $8.75 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $95,719 - $108,498	1,308 Added 1.28%	103,892 $8.62 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $1.26 Million - $1.43 Million	17,896 Added 21.13%	102,584 $7.93 Million
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $373,697 - $517,962	5,898 Added 7.49%	84,688 $6.52 Million
Q4 2019 Jan 31, 2020	BUY	$77.58 - $87.54 $723,123 - $815,960	9,321 Added 13.42%	78,790 $7.17 Million
Q3 2019 Oct 18, 2019	BUY	$76.08 - $82.93 $17,041 - $18,576	224 Added 0.32%	69,469 $5.85 Million
Q2 2019 Jul 26, 2019	SELL	$69.84 - $81.59 $812,867 - $949,626	-11,639 Reduced 14.39%	69,245 $5.81 Million
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $23,309 - $26,585	-335 Reduced 0.41%	80,884 $6.73 Million
Q4 2018 Feb 05, 2019	BUY	$65.24 - $75.71 $190,892 - $221,527	2,926 Added 3.74%	81,219 $6.21 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $78,169 - $91,923	1,355 Added 1.76%	78,293 $5.55 Million
Q2 2018 Aug 08, 2018	SELL	$50.83 - $59.72 $13,368 - $15,706	-263 Reduced 0.34%	76,938 $4.67 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $29,047 - $33,761	570 Added 0.74%	77,201 $4.21 Million
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $241,065 - $287,858	-4,670 Reduced 5.74%	76,631 $0
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $262,900 - $282,885	4,481 Added 5.83%	81,301 $5.21 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,843 Added 2.46%	76,820 $0
Q1 2017 Jan 29, 2018	SELL	N/A	-992 Reduced 1.31%	74,977 $4.76 Million
Q4 2016 Jan 29, 2018	BUY	N/A	3,179 Added 4.37%	75,969 $0
Q3 2016 Jan 29, 2018	BUY	N/A	31,573 Added 76.6%	72,790 $4.54 Million
Q2 2016 Jan 29, 2018	BUY	N/A	35,939 Added 680.92%	41,217 $0
Q1 2016 Jan 29, 2018	SELL	N/A	-505 Reduced 8.73%	5,278 $279,000
Q3 2015 Jan 29, 2018	SELL	N/A	-178 Reduced 2.99%	5,783 $286,000
Q2 2015 Jan 29, 2018	SELL	N/A	-940 Reduced 13.62%	5,961 $0
Q1 2015 Jan 29, 2018	BUY	N/A	1,095 Added 18.86%	6,901 $397,000
Q4 2014 Jan 29, 2018	BUY	N/A	5,806	5,806 $0

Others Institutions Holding MRK

# of Institutions

3,770

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account